Glenmede Trust’s Immunogen Inc IMGN Stock Holding History

Glenmede Trust’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,813	Closed	-$552K	–	1348
2023 Q3	$552K	Buy	+34,813	New	+$579K	﹤0.01%	813
2017 Q3	–	Sell	-102	Closed	–	–	2866
2017 Q2	$0	Hold	102	–	–	﹤0.01%	2700
2017 Q1	$0	Buy	+102	New	+$298	﹤0.01%	2766
2014 Q2	–	Sell	-130	Closed	-$1K	–	2403
2014 Q1	$1K	Sell	130 -617	-83%	-$9.73K	﹤0.01%	2297
2013 Q4	$10K	Buy	+747	New	+$11.5K	﹤0.01%	1996
2013 Q3	–	Sell	-354	Closed	-$5K	–	2274
2013 Q2	$5K	Buy	+354	New	+$5.74K	﹤0.01%	2006

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glenmede Trust's IMGN Position: Q4 2023 in Review

Glenmede Trust sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 34,813 shares — an estimated $552K sold.

Glenmede Trust first reported a position in IMGN in Q2 2013 and held it in 6 quarters. The position peaked at $552K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Glenmede Trust reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Glenmede Trust sold 34,813 Immunogen Inc shares in Q4 2023, an estimated $552K.
Glenmede Trust first reported a position in Immunogen Inc in Q2 2013 and held it in 6 quarters.
Glenmede Trust's Immunogen Inc position peaked at $552K in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Glenmede Trust's 13F filing for Q4 2023, filed 13 Feb 2024.